EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Therapeutic Drug Monitoring of Voriconazole Based on High-Performance Liquid Chromatography: A Single-Center Pilot Study in Outpatients

Satoru Morikawa, Yusuke Yagi iD, Moemi Okazaki, Narika Yanagisawa, Tomoaki Ishida iD, Kohei Jobu iD, Takumi Maruyama iD, Takahiro Kato iD, Miyuki Matsushita, Yu Arakawa iD, Yuka Yamagishi, Yukihiro Hamada iD

Antibiotics · 08.05.2025 · 14 (5) · 474

DOI: 10.3390/antibiotics14050474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 08.05.2025. Verfasst von Satoru Morikawa und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Kochi Medical School Hospital, 185-1 Kohasu, Oko-town, Nankoku 783-8505, Japan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Voriconazole (VRCZ) use requires accurate monitoring to avoid suboptimal drug levels and adverse effects. In addition, the appearance of resistant fungal strains is a problem that needs attention. Blood concentration measurement is the monitoring technique of choice; however, it is slow, limiting its clinical application. This study aimed to evaluate the clinical utility of rapid therapeutic drug monitoring (TDM) for VRCZ using high-performance liquid chromatography with ultraviolet detection (HPLC-UV) compared to conventional outsourced liquid chromatography–tandem mass spectrometry (LC-MS/MS) testing in outpatient care.

Methods

VRCZ blood concentrations were measured using HPLC-UV and LC-MS/MS. Reporting times, accuracy, and clinical outcomes were assessed for outpatients receiving VRCZ treatment. Safety was monitored for renal, hepatic, and visual toxicities.

Results

HPLC-UV significantly reduced reporting times (0.433 h vs. 74.3 h, p < 0.001), and Deming’s regression analyses showed a strong correlation with LC-MS/MS results (Pearson’s r = 0.988). Bland–Altman analysis showed an average difference of 0.025 μg/mL between HPLC-UV and LC-MS/MS. Prospective monitoring of three outpatients revealed no adverse events, enabling safe and effective VRCZ dosing.

Conclusions

Rapid VRCZ TDM using HPLC-UV is a cost-effective and feasible approach for outpatient care, significantly improving reporting times and patient safety. Further studies and cross-facility collaboration are needed to expand its application.

Schlagwörter

Stichwörter der Autor:innen

adverse eventshigh-performance liquid chromatographyoutpatient carerapid therapeutic drug monitoringvoriconazole

Autor:innen und Institutionen

  • Department of Pharmacy, Kochi Medical School Hospital, 185-1 Kohasu, Oko-town, Nankoku 783-8505, Japan.
  • Department of Chromatography Sales, Hitachi High-Tech Analysis Corporation, Tokyo 105-6409, Japan.
  • Department of Infection Prevention and Control, Kochi Medical School Hospital, Nankoku 783-8505, Japan.
  • Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-0001, Japan.
  • Department of Clinical Infectious Diseases, Kochi Medical School, Kochi University, Kochi 780-8072, Japan.

ORCID-Profile: Yusuke Yagi, Tomoaki Ishida, Kohei Jobu, Takumi Maruyama, Takahiro Kato, Yu Arakawa, Yukihiro Hamada

Förderung

  • JSPS KAKENHI

Zitieren

APA

Morikawa, S., Yagi, Y., Okazaki, M., Yanagisawa, N., Ishida, T., Jobu, K., Maruyama, T., Kato, T., Matsushita, M., Arakawa, Y., Yamagishi, Y., & Hamada, Y. (2025). Rapid Therapeutic Drug Monitoring of Voriconazole Based on High-Performance Liquid Chromatography: A Single-Center Pilot Study in Outpatients. Antibiotics, 14(5), 474. https://doi.org/10.3390/antibiotics14050474

Vancouver

Morikawa S, Yagi Y, Okazaki M, Yanagisawa N, Ishida T, Jobu K, et al. Rapid Therapeutic Drug Monitoring of Voriconazole Based on High-Performance Liquid Chromatography: A Single-Center Pilot Study in Outpatients. Antibiotics. 2025;14(5):474. doi:10.3390/antibiotics14050474

BibTeX
@article{Morikawa2025,
  author = {Morikawa, Satoru and Yagi, Yusuke and Okazaki, Moemi and Yanagisawa, Narika and Ishida, Tomoaki and Jobu, Kohei and Maruyama, Takumi and Kato, Takahiro and Matsushita, Miyuki and Arakawa, Yu and Yamagishi, Yuka and Hamada, Yukihiro},
  title = {Rapid Therapeutic Drug Monitoring of Voriconazole Based on High-Performance Liquid Chromatography: A Single-Center Pilot Study in Outpatients},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {474},
  doi = {10.3390/antibiotics14050474}
}
Kostenlos starten →